H.R. 124
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
In Plain Language
This bill lets states get federal Medicaid money to cover half the cost of educating people with sickle cell disease about the risks of renal medullary carcinoma, a rare kidney disease. The federal government would pay for 50% of these education programs, while states would cover the other half.
Official Congressional Research Service summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Sponsor
Cosponsors
None listed
Latest action
Referred to the House Committee on Energy and Commerce.
Jan 3, 2025
Official source
Action history
Write to this bill’s sponsor
Draft a constituent message about this bill in your own words -- grounded in the actual summary, not a form letter.
Don’t worry — we’ll help you form the message.
Compose a message